Résultats de la recherche - Nobuo Kanazawa

Induced pluripotent stem cells representing Nakajo-Nishimura syndrome par Nobuo Kanazawa, Fumiko Honda-Ozaki, Megumu K. Saito

Connect to this object online.

Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis par Kanako Kita, Yasutomo Imai, Makoto Nagai, Masaru Natsuaki, Nobuo Kanazawa

Connect to this object online.

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS) par Nobuo Kanazawa, Taeko Ishii, Yasushi Takita, Atsushi Nishikawa, Ryuta Nishikomori

Connect to this object online.

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab par Shoko Miyamoto, Yasutomo Imai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa

Connect to this object online.

Dupilumab in atopic dermatitis patients with chronic hepatitis B par Masako Matsutani, Yasutomo Imai, Minori Nakatani‐Kusakabe, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa

Connect to this object online.

<i>NOD</i>2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination par Akiko Arakawa, Naotomo Kambe, Ryuta Nishikomori, Akiyo Tanabe, Masamichi Ueda, Chikako Nishigori, Yoshiki Miyachi, Nobuo Kanazawa

Connect to this object online.

Sustained Surface ICAM-1 Expression and Transient PDGF-B Production by Phorbol Myristate Acetate-Activated THP-1 Cells Harboring Blau Syndrome-Associated <em>NOD2</em> Mutations par Mizuho Nishiyama, Hong-jin Li, Ikuo Okafuji, Akihiko Fujisawa, Mizue Ehara, Naotomo Kambe, Fukumi Furukawa, Nobuo Kanazawa

Connect to this object online.

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and... par Minori Nakatani-Kusakabe, Koubun Yasuda, Michio Tomura, Makoto Nagai, Kiyofumi Yamanishi, Etsushi Kuroda, Nobuo Kanazawa, Yasutomo Imai

Connect to this object online.

Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice par Marin Kunimoto, Yasutomo Imai, Masako Matsutani, Minori Nakatani‐Kusakabe, Makoto Nagai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa

Connect to this object online.

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study par Yutaka Inaba, Nobuo Kanazawa, Kyoko Muraoka, Azusa Yariyama, Ami Kawaguchi, Kayo Kunimoto, Chikako Kaminaka, Yuki Yamamoto, Kaoru Tsujioka, Akira Yoshida, Teruki Yanagi, Masatoshi Jinnin

Connect to this object online.